Skip to main content
Clinical Trials/NCT04370067
NCT04370067UnknownNot Applicable

Hungarian CoronaVirus Disease-19 Epidemiological Research

Semmelweis University Heart and Vascular Center4 sites in 1 country11,200 target enrollmentStarted: May 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
11,200
Locations
4
Primary Endpoint
COVID-19 rate

Study Overview

Brief Summary

Hungarian CoronaVirus disease-19 Epidemiological Research

Detailed Description

The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Other

Eligibility Criteria

Ages
14 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Hungarian male or female patients aged 14 and over who live in private households
  • •Inactivated social security number does not infer the exclusion of the study

Exclusion Criteria

  • •Patients under the age of 14
  • •Patients living in institutional households

Outcomes

Primary Outcomes

COVID-19 rate

Time Frame: 1 year

The rate of the infected patients, asymptomatic carrier and healed patients

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Semmelweis University Heart and Vascular Center
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials